COM:QUELL-TX
Quell Therapeutics
- Privately Held
Preview
Full access is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Photo | Title | Links |
---|---|---|
Iain McGillCEO | ||
Aaron VernonChief Manufacturing Officer | ||
Luke HenryChief Business Officer | ||
Luke DeveyChief Medical Officer | ||
Marc Martinez-LlordellaCo-founder & VP Biology | ||
Julien BrowneAssociate Director Head Analytical Development | ||
Laura FryHead of Cell Processing | ||
Aleks GuvenelAssociate Director - Head of Process Development | ||
Hayley ThomasDirector of Risk & Financial Control | ||
Alan MagovernSite Director | ||
John OwersAssociate Director of Manufacturing Operations | ||
Rupert KenefeckSenior Director Translational Medicine | ||
Lauren GuyAssociate Director, FP&A | ||
Jie WangSenior Director, Clinical Development | ||
David CollinSenior Director of Clinical Operation | ||
Jenny McGovernDirector/Non-Clinical Group Leader | ||
Rupert BakerIT Director | ||
Robert KallmeierDirector, Programme Management | ||
Sophie BrayneDirector Business Development | ||
Paul CarterSenior Director MSAT | ||
Daniela PenstonDirector/Team Lead Discovery and New Technologies | ||
Nikola N.Senior Director, Portfolio Strategy and Alliance Management | ||
Urvi ThackerAssociate Director MSAT | ||
Seb HodgkinSenior Director Quality Assurance |